NCT02541955CompletedPhase 4
Use of Acthar in Rheumatoid Arthritis (RA) Related Flares
Use of Acthar in Rheumatoid Arthritis Related Flares
Source: ClinicalTrials.gov · Last updated 11 Aug 2026
Brief summary (registry, in English)
This is a Rheumatoid Arthritis (RA) study. The purpose of this research study is to determine in RA flare, whether musculoskeletal ultrasound (MSUS) inflammatory scores and/or disease activity scores improve with Acthar treatment.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 1 Sept 2015
- Start date
- 20 Jul 2017
- Primary completion date
- 6 May 2025
- Lead sponsor
- Veena Ranganath, MD, MS
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT02541955
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 40
- From 20 Jul 2017 to the primary completion date, 6 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior treatment with Acthar in the past 2mos
- Subjects who have received live or live attenuated vaccines within 6 weeks prior to the first dose of study drug (or the zoster vaccine)
Other
- Meet one of the above RA flare requirements
Who the study is looking for
- Patient must meet 1987 ACR criteria
- Age \> 18 years of age
- Baseline DAS28/Erythrocyte Sedimentation Rate (ESR) \>=3.2
- Stable concomitant Disease Modifying Anti-Rheumatic Drugs (DMARDs)
- Stable prednisone \<10mg or equivalent
- Power Doppler score of \>=10
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UCLA David Geffen School of Medicine, Division of Rheumatology Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.